Saturday Afternoon Live: Dr. Steven Treon’s Presentation at the 2019 IWMF Educational Forum June 8th will be Streamed Online!

The International Waldenstrom's Macroglobulinemia Foundation (IWMF) is a nonprofit organization founded by patients. Their mission? Support patients currently living with Waldenstrom's Macroglobulinemia (WM) while simultaneously supporting the search for a…

Continue Reading Saturday Afternoon Live: Dr. Steven Treon’s Presentation at the 2019 IWMF Educational Forum June 8th will be Streamed Online!
England’s NHS Reaches Agreement for Coverage with SMA Drug Manufacturer Biogen
source: pixabay.com

England’s NHS Reaches Agreement for Coverage with SMA Drug Manufacturer Biogen

According to a publication from Express Digest, Britain's National Health Service (NHS) has finally reached an agreement with American biotechnology company Biogen Inc. over the price of Spinraza - a…

Continue Reading England’s NHS Reaches Agreement for Coverage with SMA Drug Manufacturer Biogen
Experimental Treatment for Multiple Myeloma Earns Orphan Drug Designation
stevepb / Pixabay

Experimental Treatment for Multiple Myeloma Earns Orphan Drug Designation

According to a story from globenewswire.com, the biopharmaceutical company Poseida Therapeutics, Inc. recently announced that the company's investigational product candidate P-BCMA-101 has been granted Orphan Drug Designation from the US…

Continue Reading Experimental Treatment for Multiple Myeloma Earns Orphan Drug Designation
This Spinocerebellar Ataxia Patient is Committed to Spreading Awareness
cocoparisienne / Pixabay

This Spinocerebellar Ataxia Patient is Committed to Spreading Awareness

According to a story from Kamloops Coffee Talk, Darrin Rein, of Kamloops, British Columbia, was just recently diagnosed with spinocerebellar ataxia, a rare disease that affects mobility and coordination. Despite…

Continue Reading This Spinocerebellar Ataxia Patient is Committed to Spreading Awareness

Could Stopping Using the Word “Rare” Increase the Rate of Diagnosis for Rare Disease Patients?

The Word "Rare" Unfortunately, many experts in rare disease believe the phrase "rare disease" may be harming the very population it describes. The Director of the National Center for Advancing…

Continue Reading Could Stopping Using the Word “Rare” Increase the Rate of Diagnosis for Rare Disease Patients?

Resort City in California has Made Their Beaches Wheelchair Accessible with Temperature Controlled Mats

Coronado is a resort city located in San Diego, California. It's known for its luxury hotels, delicious restaurants, beautiful parks, and gorgeous beaches. It has just been announced that the…

Continue Reading Resort City in California has Made Their Beaches Wheelchair Accessible with Temperature Controlled Mats

Learn About These Rare Eye Diseases to Honor Healthy Vision Month!

May is Healthy Vision Month! Rare disease or not, maintaining healthy eye health should be a priority for all of us. The National Institute of Health has resources for not…

Continue Reading Learn About These Rare Eye Diseases to Honor Healthy Vision Month!

Experimental Treatment for Genetic Amyotrophic Lateral Sclerosis Shows Potential in Trial

According to a story from BioSpace, the drug developer Biogen recently released interim results from a Phase 1/2 clinical trial. This clinical trial is testing the drug tofersen, which is…

Continue Reading Experimental Treatment for Genetic Amyotrophic Lateral Sclerosis Shows Potential in Trial
Experimental Treatment for Multiple Myeloma Earns Orphan Drug Designation
stevepb / Pixabay

Experimental Treatment for Multiple Myeloma Earns Orphan Drug Designation

According to a story from globenewswire.com, the biopharmaceutical company Poseida Therapeutics, Inc. recently announced that the company's investigational product candidate P-BCMA-101 has been granted Orphan Drug Designation from the US…

Continue Reading Experimental Treatment for Multiple Myeloma Earns Orphan Drug Designation
An Experimental Treatment for Adenoid Cystic Carcinoma Earns Orphan Drug Designation
DarkoStojanovic / Pixabay

An Experimental Treatment for Adenoid Cystic Carcinoma Earns Orphan Drug Designation

According to a story from apnews.com, the drug developer Ayala Pharmaceuticals has recently announced that the company's investigational product candidate, known as as AL101, has earned Orphan Drug Designation. This…

Continue Reading An Experimental Treatment for Adenoid Cystic Carcinoma Earns Orphan Drug Designation

NIH Reverses Decision, Allows Doctors to Speak to Federal Investigators About Sepsis Study Objections

According to the Wall Street Journal, the National Institutes of Health (NIH) has reversed its initial decision to prevent two of its researchers from meeting with federal investigators to comment…

Continue Reading NIH Reverses Decision, Allows Doctors to Speak to Federal Investigators About Sepsis Study Objections

New Bill Could Allow Easier Access to Complex Rehabilitation Technology for Rare Disease Patients

H.R. 2408 H.R. 2408 is a new piece of federal legislation otherwise known as the "Ensuring Access to Quality Complex Rehabilitation Technology Act." Essentially, this act creates a new category…

Continue Reading New Bill Could Allow Easier Access to Complex Rehabilitation Technology for Rare Disease Patients